Carl June: h-index, Total Citations, and Citation Map
Carl June's h-index is 213 (798 i10-index, 209,425+ total citations across 1,000+ publications) according to Google Scholar as of July 2026. Carl June is affiliated with University of Pennsylvania.
Carl June is a researcher affiliated with University of Pennsylvania, specializing in various fields. Their work has been cited 209,425 times. This profile visualizes their global influence, highlighting strong citation networks in China.
Carl June's Citation Metrics
Bibliometric impact based on 1,000 indexed publications.
- H-Index
- 213
- i10-Index
- 798
- Total Citations
- 209,425
- Citing Countries
- 55
As of July 2026.
Carl June has an h-index of 213 and 209,425 total citations across 1000 publications, with research cited by institutions in 55 countries.
Download Exports (PNG, CSV, Poster)
Free Viewing Carl June's citation map is always free. Pay once to download poster, PNG, and CSV files for offline use or your visa packet.
Global Impact Map
Visualizing the geographic distribution of institutions that have cited your work.
Starting…
Pins will appear here as institutions are resolved — no need to refresh.
Chimeric antigen receptor T cells for sustained remissions in leukemia
20146,915
Top Citing Countries
Top Citing Institutions
Visa Evidence Package
Views and exports tuned for EB-1A, O-1A, and EB-2 NIW petitions. Sustained acclaim, geographic reach, and independent-citation filtering are the strongest evidence categories immigration adjudicators look for.
Significant Contributions
Auto-detected research lines — a seminal paper and the follow-up work building on it. Review and edit before using in a petition. Each Free PDF opens in a new tab — EB-1A organises this into the structure USCIS applies to Criterion 5 of 8 CFR § 204.5(h)(3)(v); EB-1B re-frames it under § 204.5(i)(3) (outstanding researcher); NIW presents it under prong 2 of Matter of Dhanasar.
10 citing papers could not be classified (no author data) — excluded from the percentages above.
The researcher advanced CAR T-cell therapy for leukemia, demonstrating its potential for sustained remissions in a seminal 2014 study that established a critical benchmark in immunotherapy.
The researcher published a seminal study on tisagenlecleucel for pediatric B-cell lymphoblastic leukemia, establishing a critical benchmark in CAR-T cell therapy with over 6,800 citations.
The researcher advanced CAR-T cell therapy for chronic lymphoid leukemia, establishing a foundational framework widely adopted by the independent scientific community.
Citation trend (last 10 years)Click to expand
Citation Trend (Last 10 Years)
Related Guides
Learn how to use citation maps for your research and visa applications.
About Carl June's research
Carl June is a researcher at University of Pennsylvania. Their work has been cited 209,425 times across 1,000 publications (h-index 213), according to Google Scholar.
Their most-cited work, “Chimeric antigen receptor T cells for sustained remissions in leukemia” (2014), has accumulated 6,915 citations. Other influential works include “Tisagenlecleucel in children and young adults with B-cell lymphoblastic leukemia” (2018) with 6,818 citations and “Chimeric antigen receptor–modified T cells in chronic lymphoid leukemia” (2011) with 5,107 citations.
Citations of Carl June's research come primarily from China, United States and United Kingdom, reflecting international research impact across 5+ countries. The interactive citation map above shows the full geographic distribution of the institutions citing this work.
